Pandemic preparedness and response are quintessential “global public goods”: unless the new coronavirus is controlled everywhere, the risk of pandemic resurgence remains. This paper presents the key role of development finance in helping developing countries’ health systems prepare and...

All OECD countries have established vaccination programmes based on their interpretation of the risks and benefits of each vaccine. There is strong evidence that vaccines provide safe and effective protection against diseases such as diphtheria, tetanus, pertussis (whooping cough), and measles....

Influenza is a common infectious disease that affects many people. Most people with influenza recover quickly, but elderly people and those with chronic medical conditions are at higher risk of complications and even death. Influenza vaccination rate refers to the number of people aged 65 and...

Health systems continue to adapt to cope with the COVID‑19 pandemic. Much focus has been placed on the scaling-up of hospital capacities. However, the pandemic is also deeply affecting the health of many people who are not infected by the virus. People living with chronic conditions are not...

The coronavirus (COVID-19) pandemic highlights the need for a comprehensive and integrated approach to human health. Enhancing environmental health through better air quality, water and sanitation, waste management, along with efforts to safeguard biodiversity, will reduce the vulnerability of...

Health systems are facing the most serious global pandemic crisis in a century. The main focus of this brief is on the policies aimed at providing effective care and managing the pressure on health systems.

In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for...